QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
NYSE:NGVT

Ingevity - NGVT Stock Forecast, Price & News

$73.84
-0.21 (-0.28%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$73.30
$74.89
50-Day Range
$60.63
$78.95
52-Week Range
$56.31
$79.79
Volume
114,616 shs
Average Volume
201,765 shs
Market Capitalization
$2.76 billion
P/E Ratio
12.71
Dividend Yield
N/A
Price Target
$80.00

Ingevity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
8.3% Upside
$80.00 Price Target
Short Interest
Healthy
1.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.07mentions of Ingevity in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$194,424 Sold Last Quarter
Proj. Earnings Growth
13.06%
From $6.43 to $7.27 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Basic Materials Sector

114th out of 163 stocks

Chemicals & Allied Products Industry

10th out of 14 stocks

NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Stock News Headlines

Ingevity reports third quarter 2022 financial results
Here's Why Ingevity (NGVT) is a Strong Growth Stock
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
Here's Why Ingevity (NGVT) Looks Ripe for Bottom Fishing
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Company Calendar

Last Earnings
11/02/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/22/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
1,850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$80.00
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$73.00
Forecasted Upside/Downside
+8.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$118.10 million
Pretax Margin
17.66%

Debt

Sales & Book Value

Annual Sales
$1.39 billion
Cash Flow
$8.16 per share
Book Value
$17.15 per share

Miscellaneous

Free Float
37,107,000
Market Cap
$2.76 billion
Optionable
Optionable
Beta
1.78

Key Executives

  • Mr. John C. Fortson (Age 55)
    Pres, CEO & Director
    Comp: $2.35M
  • Ms. Mary Dean Hall (Age 64)
    Exec. VP & CFO
    Comp: $1.03M
  • Ms. Stacy Lancaster Cozad (Age 51)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.39M
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 56)
    Exec. VP & Pres of Performance Materials
    Comp: $831.57k
  • Mr. Phillip John Platt (Age 41)
    Chief Accounting Officer, Corp. Controller & VP of Financial Planning
  • Mr. Daniel Gallagher
    VP of Investor Relations
  • John Nypaver
    VP of Treasurer & Investor Relations
  • Ms. Christine Stunyo
    Sr. VP & Chief HR Officer
  • Mr. Richard White (Age 59)
    Sr. VP of Performance Chemicals and Pres of Industrial Specialties & Pavement Technologies
  • Mr. Erik Ripple
    Sr. VP and Chief Growth & Innovation Officer













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NGVT shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2023?

2 brokerages have issued 12 month price targets for Ingevity's shares. Their NGVT share price forecasts range from $73.00 to $87.00. On average, they expect the company's stock price to reach $80.00 in the next twelve months. This suggests a possible upside of 8.3% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2022?

Ingevity's stock was trading at $71.70 at the beginning of the year. Since then, NGVT shares have increased by 3.0% and is now trading at $73.84.
View the best growth stocks for 2022 here
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its quarterly earnings results on Wednesday, November, 2nd. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.72 by $0.37. The company earned $482 million during the quarter, compared to analysts' expectations of $428.39 million. Ingevity had a net margin of 13.90% and a trailing twelve-month return on equity of 36.37%.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.65 billion-$1.70 billion, compared to the consensus revenue estimate of $1.60 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.03%), Vanguard Group Inc. (9.65%), State Street Corp (3.20%), LSV Asset Management (2.78%), Thrivent Financial for Lutherans (2.57%) and Massachusetts Financial Services Co. MA (2.49%). Insiders that own company stock include D Michael Wilson, Diane H Gulyas, Erik Spencer Ripple, Frederick J Lynch, John C Fortson, Michael P Smith, Richard Allen White Jr, Richard B Kelson and Stuart Edward Jr Woodcock.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $73.84.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $2.76 billion and generates $1.39 billion in revenue each year. The company earns $118.10 million in net income (profit) each year or $5.81 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 1,850 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (844) 643-8489, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 12/8/2022 by MarketBeat.com Staff